Search filters

List of works by Gennaro Daniele

A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors.

scientific article published on 2 October 2014

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

scientific article published in January 2015

Addition of erlotinib to fluoropyrimidine-oxaliplatin-based chemotherapy with or without bevacizumab: Two sequential phase I trials

scientific article

Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations: current evidence and future perspectives

scientific article published on October 2013

Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors

scientific article published on 12 August 2015

Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence.

scientific article published on February 2011

Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study

scientific article published on 12 March 2012

Cetuximab in non-small-cell lung cancer

Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC: we should have known better….

scientific article published on January 2014

Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs

scientific article

FGF receptor inhibitors: role in cancer therapy

scientific article published on April 2012

Gefitinib in non small cell lung cancer

scientific article

Integrated therapeutic approaches in the treatment of locally advanced non-small cell lung cancer

scientific article published on July 2013

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial.

scientific article published on 4 April 2013

New biological treatments for gynecological tumors: focus on angiogenesis

scientific article published on 06 January 2014

New drugs in advanced non-small-cell lung cancer: searching for the correct clinical development

scientific article

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

scientific article published on 14 April 2015

Pharmacokinetic evaluation of capecitabine in breast cancer

scientific article published on 10 January 2013

Pharmacokinetic evaluation of zoledronic acid.

scientific article published on 13 May 2011

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

scientific article

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

scientific article published on 31 July 2015

Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials

scientific article published on 31 January 2012

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study

scientific article published in May 2013

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials

scientific article published on 26 January 2015

Time spent for activation of non-profit studies in oncology in Italy

scientific article

Treatment of small cell lung cancer

scholarly article by Alessandro Morabito et al published September 2014 in Critical Reviews in Oncology Hematology

Vandetanib: An overview of its clinical development in NSCLC and other tumors.

scientific article published on September 2010

Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells.

scientific article

Vinorelbine for non-small cell lung cancer.

scientific article published on May 2010

Paulina is supported by:

About Paulina

Help